Polyinosinic: polycytidylic acid (PrEP Biopharm)

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NamePolyinosinic: polycytidylic acid (PrEP Biopharm)
Drug Alias NamePolyinosinic-polycytidylic acid sodium saltPrEP-001JNJ-43260295
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoic acid-inducible gene I modulatorsToll-like receptor agonists
TargetsToll-like receptorRetinoic acid-inducible gene I
Therapy Area/IndicationsAsthmaRespiratory Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson Innovative Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPrep Biopharm LtdJanssen Research & Development Llc
Active IndicationsN/A
Inactive IndicationsAsthmaRespiratory Tract Infections

Other Information

ATC CodeN/A
Related LinksN/A